Haemoctin SDH

Bleeding treatment & prophylaxis in patients w/ haemophilia A. Management of acquired factor VIII deficiency.

IV Individualized dosage based on severity of factor VIII deficiency, location & extent of bleeding & patient's clinical condition. Early haemarthrosis, muscle or oral bleeding (20-40%) 12-24 hrly for at least 1 day until bleeding episode is resolved or healing is achieved. More extensive haemarthrosis, muscle bleeding or haematoma (30-60%) 12-24 hrly infusion for 3-4 days or more until pain & acute disability are resolved. Life-threatening haemorrhages (60-100%) 8-24 hrly infusion until threat is resolved. Minor surgery including tooth extraction (30-60%) 24 hrly for at least 1 day until healing is achieved. Major surgery (80-100% pre- & postop) 8-24 hrly until adequate wound healing, then repeat therapy for at least 7 days to maintain 30-60% factor VIII activity. Long-term bleeding prophylaxis Patient w/ severe haemophilia A 20-40 IU/kg at 2-3 days intervals.

Hypersensitivity.

Haemostatics

B02BD02 - coagulation factor VIII ; Belongs to the class of blood coagulation factors. Used in the treatment of hemorrhage.

POM